Peter J Hosein

9PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsCellular nervous systemCancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2026
Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial.

|Jan 15, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Daniel R Carrizosa, Michael Rothe, Pam K Mangat

|Oct 29, 2025
Dethroning of Neuroendocrine Tumor as an Orphan Disease: US Incidence, Prevalence, and Survival in the 21st Century.

Qian Yu, Fan Cao, Peter Hosein

|Sep 15, 2025
Impact of new onset diabetes on pancreatic cancer outcomes.

Casey P Borowsky, Peter J Hosein

|Dec 03, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

Thomas J George, Ji-Hyun Lee, David L DeRemer

|May 09, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.

Erik B Faber, Harris B Krause, Khalid Amin

Pageof 2

Frequent Collaborators

2 joint publications

Ignacio Garrido-Laguna

2 joint publications

Matthew Oberley

2 joint publications

Jashodeep Datta

2 joint publications

Vaia Florou